Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador

  • Aleksandra Yakhkind
  • , Adam Edward Lang*
  • , Gretchen Brophy
  • , Eljim Tesoro
  • , Kimberly E. Levasseur-Franklin
  • , Nelson Maldonado
  • *Autor correspondiente de este trabajo
  • Tufts University School of Medicine
  • McDonald Army Health Center
  • Virginia Commonwealth University
  • Virginia Commonwealth University
  • University of Illinois at Chicago
  • Tufts Medical Center

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

2 Citas (Scopus)

Resumen

Medicines have been developed and have become globalized at a pace faster than traditional medical education can keep up. Physicians, pharmacists, nurses, and advanced practice providers learn the names and functions of these medications, but not how they are made and how they get to the bedside. The often economically driven intricacies behind these processes have a dramatic effect on patient care and outcomes. A staggering proportion of medications worldwide are reported to be substandard or falsified. This article explores one country’s story of how medication gets to the bedside, describes how this process can go wrong, and outlines what providers can do to work toward the goal of equitable access to quality medications for all.

Idioma originalInglés
Páginas (desde-hasta)1-6
Número de páginas6
PublicaciónNeurocritical Care
Volumen38
N.º1
DOI
EstadoPublicada - 14 dic. 2022

Huella

Profundice en los temas de investigación de 'Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador'. En conjunto forman una huella única.

Citar esto